Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lenox Pasifik Investama Tbk. (LPPS) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance

Lenox Pasifik Investama Tbk.Trade
Charlie Hospital Semarang Tbk.Trade

Price performance (Past 24H)

Key statistics

Lenox Pasifik Investama Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Lenox Pasifik Investama Tbk. trades at Rp80 (market cap 212.24B, 1.08M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp310 (market cap 816.2B, 25.44M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 3.8× Lenox Pasifik Investama Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.44M versus 1.08M). Which is the better fit depends on your goals.

LPPSRSCH
Market Cap
212.24B816.2B
Volume
1.08M25.44M
Lot
10.79K254.36K
Turnover
88.36M7.84B
Average Price
81.87308.07
Value
88.36M7.84B
Indicative Equilibrium Price
80310
Indicative Equilibrium Volume
50100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LPPS
View details
RSCH
View details

About Lenox Pasifik Investama Tbk.

PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.

Read more on LPPS

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH